Serum Concentrations of Transforming Growth Factor β1 in Patients with Psoriasis Vulgaris

Acta Dermatovenerologica Croatica

Volumn 12, Issue 1, 2004, Pages 2-6

  Nockowski, Piotr ^a,b   Szepietowski, Jacek C ^a   Ziarkiewicz, Marek ^a   Baran, Eugeniusz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cytokines; Psoriasis; Transforming growth factor beta

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PSORIASIS VULGARIS; RESPIRATORY TRACT INFECTION; SKIN DISEASE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 1942488905     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Christophers E. The immunopathology of psoriasis. Int Arch Allergy Immunol 1996;110:199-206.
2. Griffiths CE, Voorhees JJ. Psoriasis, T-cell and autoimmunity. J R Soc Med 1996;89:315-9.
3. Pacan P, Szepietowski J, Kiejna A. Influence of psychic factors on the course of psoriasis. Przegl Dermatol 2002;89:401-8.
4. Luszczek W, Kubicka W, Cislo M, Nockowski P, Manczak M, Woszczek G, et al. Strong association of HLA-Cw6 allele with juvenile psoriasis in Polish patients. Immunol Lett 2003;85:59-64.
5. Bonifati C, Ameglio F. Cytokines in psoriasis. Int J Dermatol 1999;38:244-51.
6. Szepietowski J, Walker C, Hunter JA, McKenzie RC. Elevated leukaemia inhibitory factor (LIF) expression in lesional psoriatic skin: correlation with interleukin (IL)-8 expression. J Dermatol 2001;28:115-22.
7. Szepietowski JC, Bielicka E, Nockowski P, Noworolska A, Wasik F. Increased interleukin-7 levels in the sera of psoriatic patients: lack of correlation with interleukin-6 levels and disease intensity. Clin Exp Dermatol 2000; 25:643-7.
8. Flisiak I, Chodynicka B. Transforming growth factor β and skin. Przegl Dermatol 2001;88:181-7.
9. 1 a general review. Eur Cytokine Netw 1996;7:363-74.
10. Fredriksson T, Peterson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978;157:238-41.
11. Szepietowski JC, Sikora M, Pacholek T, Dmochowska A. Clinical evaluation of Self-Administered Psoriasis Area and Severity Index (SAPASI). Acta Dermatovenerologica Alpina, Pannonica et Adriatica 2001;10:79-83.
12. 1 are increased in the serum of patients with psoriasis and correlate with disease severity. Eur J Dermatol 1996;6:486-90.
13. 2 in plasma and scales from psoriatic lesions. Cytokine 2002;19:121-5.
14. Czech W, Schopf E, Kapp A. Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis - correlation with disease activity. Br J Dermatol 1996;136: 17-21.
15. Tigalonova M, Bjerke JR, Gallati H. Serum levels of interferons and TNF-α are not correlated to psoriasis activity and therapy. Acta Derm Venereol (Stockh) Suppl 1994;186:25-7.
16. Border WA, Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest 1992;90:1-7.
17. McKenzie RC, Boyce F, Szepietowski JC, Forsey RJ, Howie SE, Hunter JA, et al. Psoriatic epidermis express high levels of interleukin 18 (IL-18), IL-18 receptor mRNA and IL-18 protein. Dermatologia Kliniczna 2002;4:17-23.
18. Schmid P, Cox O, McMaster GK, Itin P. In situ hybridization analysis of cytokine, proto-oncogene and tumour suppressor gene expression in psoriasis. Arch Dermatol Res 1993;285:334-40.
19. Elder JT, Fisher GJ, Lindquist PB, Bennett GL, Pittelkow MR, Coffey RJ Jr, et al. Overexpression of transforming growth factor α in psoriatic epidermis. Science 1989; 243:811-4.
20. 1 localization in normal and psoriatic epidermal keratinocytes in situ. J Cell Physiol 1990;144:144-50.